<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4--><!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
   <PublisherInfo>
      <PublisherName>Springer-Verlag</PublisherName>
      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
   </PublisherInfo>
   <Journal>
      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">
         <JournalID>401</JournalID>
         <JournalPrintISSN>0001-6322</JournalPrintISSN>
         <JournalElectronicISSN>1432-0533</JournalElectronicISSN>
         <JournalSPIN/>
         <JournalTitle>Acta Neuropathologica</JournalTitle>
         <JournalSubTitle/>
         <JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Legacy</JournalSubject>
</JournalSubjectGroup>
      </JournalInfo>
      <Volume>
         <VolumeInfo VolumeType="Regular">
<VolumeIDStart>101</VolumeIDStart>
<VolumeIDEnd>101</VolumeIDEnd>
<VolumeIssueCount/>
</VolumeInfo>
         <Issue IssueType="Regular">
            <IssueInfo TocLevels="0">
               <IssueIDStart>3</IssueIDStart>
               <IssueIDEnd>3</IssueIDEnd>
               <IssueHistory>
                  <OnlineDate>
                     <Year>2001</Year>
                     <Month>2</Month>
                     <Day>1</Day>
                  </OnlineDate>
                  <PrintDate>
                     <Year>2001</Year>
                     <Month>3</Month>
                     <Day/>
                  </PrintDate>
                  <CoverDate>
                     <Year>2001</Year>
                     <Month>3</Month>
                  </CoverDate>
               </IssueHistory>
               <IssueCopyright>
                  <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                  <CopyrightYear>2001</CopyrightYear>
               </IssueCopyright>
            </IssueInfo>
            <Article ID="Art1">
               <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
                  <ArticleID>00246</ArticleID>
                  <ArticleDOI>10.1007/s004010000246</ArticleDOI>
                  <ArticleTitle Language="En">P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy</ArticleTitle>
                  <ArticleCategory>Regular paper</ArticleCategory>
                  <ArticleFirstPage>190</ArticleFirstPage>
                  <ArticleLastPage>194</ArticleLastPage>
                  <ArticleHistory>
                     <Received>
                        <Year>1999</Year>
                        <Month>12</Month>
                        <Day>23</Day>
                     </Received>
                  </ArticleHistory>
                  <ArticleCopyright>
                     <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                     <CopyrightYear>2001</CopyrightYear>
                  </ArticleCopyright>
<ArticleGrants>
<MetadataGrant Grant="OpenAccess"/>
<AbstractGrant Grant="OpenAccess"/>
<BodyPDFGrant Grant="Restricted"/>
<BodyHTMLGrant Grant="Restricted"/>
<BibliographyGrant Grant="Restricted"/>
<ESMGrant Grant="Restricted"/>
</ArticleGrants>
               </ArticleInfo>
               <ArticleHeader>
                  <AuthorGroup>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yasuyuki</GivenName>
                           <FamilyName>Honjyo</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yasuhiro</GivenName>
                           <FamilyName>Kawamoto</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Shinichi</GivenName>
                           <FamilyName>Nakamura</FamilyName>
                        </AuthorName>
                        <Contact>
                           <Phone>+81-75-7513769</Phone>
                           <Fax>+81-75-7513265</Fax>
                           <Email>nakamura@isola.kuhp.kyoto-u.ac.jp</Email>
                        </Contact>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Satoshi</GivenName>
                           <FamilyName>Nakano</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Ichiro</GivenName>
                           <FamilyName>Akiguchi</FamilyName>
                        </AuthorName>
                     </Author>
                     <Affiliation ID="A1">
                        <OrgName>Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto, 606-8507, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                  </AuthorGroup>
                  <Abstract ID="Abs1" Language="En">
                     <Heading>Abstract.</Heading>
                     <Para> Glial cytoplasmic inclusions (GCIs) characteristically occur in the oligodendrocytes of patients with multiple system atrophy (MSA). Cyclin-dependent kinase 5 (Cdk5) regulates cytoskeletal dynamism through phosphorylation of cytoskeletal proteins such as neurofilament proteins, tau and microtubule-associated protein 2. We examined the immunohistochemical localization of p39, a Cdk5 activator, in human brain specimens obtained post mortem from controls and patients with MSA. Among control specimens, p39 immunoreactivity was found in some neuronal somata and axons. Similar immunoreactivity was detected in MSA neuronal cell bodies and axons, but a number of inclusions were heavily labeled. These results suggest that p39 and Cdk5 are up-regulated in oligodendrocytes and may be involved in the formation of GCIs through phosphorylation of cytoskeletal proteins in oligodendrocytes in MSA.</Para>
                  </Abstract>
                  <KeywordGroup Language="En">
                     <Keyword>Cyclin-dependent kinase 5 Oligodendrocyte p39 Multiple system atrophy Glial cytoplasmic inclusions</Keyword>
                  </KeywordGroup>
                  <ArticleNote Type="Misc">
                     <SimplePara>Revised, accepted: 27 March 2000</SimplePara>
                  </ArticleNote>
                  <ArticleNote Type="Misc">
                     <SimplePara>Electronic Publication</SimplePara>
                  </ArticleNote>
               </ArticleHeader>
               <BodyRef FileRef="BodyRef/PDF/401_2001_Article_246.pdf" TargetType="PDF"/>
            </Article>
         </Issue>
      </Volume>
   </Journal>
</Publisher>